As an important LP (and a rare one with lots of cash to put to work), a Pharma can also influence the nature of the deals done by the fund, and can shape the macro venture fundraising environment by only investing in funds that will do early stage innovation vs later stage incremental assets.

FORBES: Debunking Corporate Venture Capital in Biotech

And at the macro level, I know it makes sense to shape the delivery of advertising around the perceived needs of customers.

FORBES: Algorithm And Blues